DuPage Medical Group Physician Provides Transoral Robotic Surgery Treatment

June 26, 2017

DOWN­ERS GROVE, Ill. — As part of DuPage Med­ical Group’s (DMG) grow­ing robot­ic surgery pro­gram, oto­laryn­gol­o­gist Dr. David Wol­raich is skilled in per­form­ing min­i­mal­ly inva­sive tran­so­ral robot­ic surgery (TORS) as a treat­ment option for oropha­ryn­geal can­cer. In recent years, research stud­ies have shown a rise in cas­es of oropha­ryn­geal can­cer linked to infec­tion with human papil­lo­ma virus (HPV).

The min­i­mal­ly inva­sive TORS pro­ce­dure involves remov­ing tumors locat­ed in the throat, the base of the tongue or the ton­sils, but with the ben­e­fits of quick­er recov­ery time, no vis­i­ble scar­ring or inci­sions and lim­it­ed blood loss dur­ing surgery. Dr. Wol­raich is one of the only sur­geons pro­vid­ing the TORS treat­ment tech­nique in the Chicagoland area.

Through the use of da Vin­ci® Sur­gi­cal Sys­tem instru­men­ta­tion, sur­geons like Dr. Wol­raich are able to more eas­i­ly reach head and neck tumors through the mouth while per­form­ing TORS. This sur­gi­cal approach allows for a guid­ed cam­era, or endo­scope, to pro­vide a high-res­o­lu­tion, 3D image of the back of the mouth and throat. The sur­geon then guides two robot­ic arms to oral tumors and safe­ly dis­sects from sur­round­ing tis­sue through inter­nal incisions.

TORS is an advanced method to treat patients with oropha­ryn­geal and oral cav­i­ty can­cers,” says Dr. Wol­raich. While treat­ing these con­di­tions in the past required large exter­nal inci­sions from lip to throat, the TORS tech­nique allows patients a range of increased ben­e­fits for com­fort and recov­ery, and pro­vides me enhanced vision, pre­ci­sion and con­trol dur­ing the entire procedure.”

Added ben­e­fits of under­go­ing the TORS pro­ce­dure, ver­sus tra­di­tion­al open­ly inva­sive surgery, include accel­er­at­ed recov­ery time. Patients usu­al­ly leave the hos­pi­tal in two to four days com­pared to sev­en days with an open pro­ce­dure. Also, patients typ­i­cal­ly main­tain swal­low­ing and speech func­tions, as well as high­ly min­i­mized risks of infec­tion or oth­er com­pli­ca­tions. With TORS, there is a high prob­a­bil­i­ty that no addi­tion­al treat­ments will be required. This decreas­es the risk of injur­ing mus­cles used to swal­low and oth­er nerves of the throat, min­i­miz­ing the impact on patients’ qual­i­ty of life post-surgery.

Dr. Wol­raich sees patients at DMG’s loca­tions in Hins­dale and Lom­bard. To make an appoint­ment, or to get a bet­ter under­stand­ing of oral can­cer treat­ment options, patients can sched­ule online or call 630−545−7576. To learn more about the future of faster recov­ery and some of the most pro­gres­sive forms of min­i­mal­ly inva­sive surg­eries avail­able today, vis­it DMG’s Robot­ic Surgery Pro­gram webpage. 

About DuPage Med­ical Group
Found­ed in 1999, DuPage Med­ical Group is the largest inde­pen­dent, mul­ti-spe­cial­ty physi­cian group with more than 600 physi­cians in over 80 sub­ur­ban Chica­go loca­tions. DMG is a patient-cen­tered orga­ni­za­tion focused on improv­ing access to con­ve­nient, qual­i­ty health care using the lat­est tech­nol­o­gy and treat­ment options. For more infor­ma­tion, vis­it www​.dupagemed​ical​.com.